94 related articles for article (PubMed ID: 12800775)
1. [Analysis of antigenic determinant profiles of the Ebola virus VP35 protein N-terminal region using its short recombinant fragments].
Rudzevich TN; Ternovoĭ VA; Kazachinskaia EI; Razumov IA; Chepurnov AA; Loktev VB; Netesov SV
Mol Gen Mikrobiol Virusol; 2003; (2):38-40, backcover. PubMed ID: 12800775
[TBL] [Abstract][Full Text] [Related]
2. [Antigenic structure of Ebola virus VP35 protein].
Kazachinskaia EI; Ternovoĭ VA; Rudzevich TN; Netesov SV; Chepurnov AA; Razumov IA
Vopr Virusol; 2001; 46(5):25-31. PubMed ID: 11715705
[TBL] [Abstract][Full Text] [Related]
3. Mapping of two dominant sites of VP35 of Marburg virus.
Sorokin AV; Kazachinskaia EI; Ivanova AV; Kachko AV; Netesov SV; Bukreyev AA; Loktev VB; Razumov IA
Viral Immunol; 2002; 15(3):481-92. PubMed ID: 12479397
[TBL] [Abstract][Full Text] [Related]
4. [Immunochemical properties of short recombinant polypeptides of proteine of, the West Nile virus bearing epitopes of domains I and II].
Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Loktev VB
Mol Biol (Mosk); 2005; 39(5):813-22. PubMed ID: 16240715
[TBL] [Abstract][Full Text] [Related]
5. Mapping of B cell epitopes in measles virus nucleocapsid protein.
Zvirbliene A; Kucinskaite I; Sezaite I; Samuel D; Sasnauskas K
Arch Virol; 2007 Jan; 152(1):25-39. PubMed ID: 16944047
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus.
Hartman AL; Bird BH; Towner JS; Antoniadou ZA; Zaki SR; Nichol ST
J Virol; 2008 Mar; 82(6):2699-704. PubMed ID: 18199658
[TBL] [Abstract][Full Text] [Related]
7. Antigenic epitopes of the hepatitis A virus polyprotein.
Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
[TBL] [Abstract][Full Text] [Related]
8. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
Hartman AL; Dover JE; Towner JS; Nichol ST
J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
[TBL] [Abstract][Full Text] [Related]
9. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
[TBL] [Abstract][Full Text] [Related]
10. Antigenic structure analysis of glycosylated protein 3 of porcine reproductive and respiratory syndrome virus.
Zhou YJ; An TQ; He YX; Liu JX; Qiu HJ; Wang YF; Tong G
Virus Res; 2006 Jun; 118(1-2):98-104. PubMed ID: 16384621
[TBL] [Abstract][Full Text] [Related]
11. C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.
Palker TJ; Scearce RM; Copeland TD; Oroszlan S; Haynes BF
J Immunol; 1986 Apr; 136(7):2393-7. PubMed ID: 2419433
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the antigenic and immunogenic properties of native and recombinant Marburg virus VP35 proteins].
Sorokin AV; Kazachinskaia EI; Kachko AV; Ivanova AV; Bukreev AA; Razumov IA
Vopr Virusol; 1999; 44(5):206-13. PubMed ID: 10544447
[TBL] [Abstract][Full Text] [Related]
13. Analysis of an immunodominant region of infectious bronchitis virus.
Kusters JG; Jager EJ; Lenstra JA; Koch G; Posthumus WP; Meloen RH; van der Zeijst BA
J Immunol; 1989 Oct; 143(8):2692-8. PubMed ID: 2477454
[TBL] [Abstract][Full Text] [Related]
14. [Immunochemical properties of West Nile virus protein prM and protein M C-end].
Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Shvalov AN; Loktev VB
Mol Biol (Mosk); 2007; 41(1):8-17. PubMed ID: 17380886
[TBL] [Abstract][Full Text] [Related]
15. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion.
Ketterlinus R; Wiegers K
Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies and conserved antigenic epitopes in the C terminus of GP5 protein of the North American type porcine reproductive and respiratory syndrome virus.
Zhou YJ; Yu H; Tian ZJ; Liu JX; An TQ; Peng JM; Li GX; Jiang YF; Cai XH; Xue Q; Wang M; Wang YF; Tong GZ
Vet Microbiol; 2009 Jul; 138(1-2):1-10. PubMed ID: 19427138
[TBL] [Abstract][Full Text] [Related]
17. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.
Hartman AL; Towner JS; Nichol ST
Virology; 2004 Oct; 328(2):177-84. PubMed ID: 15464838
[TBL] [Abstract][Full Text] [Related]
18. Comparison of coat protein epitopes of two zucchini yellow mosaic virus isolates.
Kundu AK; Ohshima K; Sako N
Acta Virol; 1998 Jun; 42(3):167-73. PubMed ID: 9842446
[TBL] [Abstract][Full Text] [Related]
19. Identification of T-helper and linear B epitope in the hypervariable region of nucleocapsid protein of PPRV and its use in the development of specific antibodies to detect viral antigen.
Dechamma HJ; Dighe V; Kumar CA; Singh RP; Jagadish M; Kumar S
Vet Microbiol; 2006 Dec; 118(3-4):201-11. PubMed ID: 16962260
[TBL] [Abstract][Full Text] [Related]
20. Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli.
Zinzula L; Esposito F; Mühlberger E; Trunschke M; Conrad D; Piano D; Tramontano E
Protein Expr Purif; 2009 Jul; 66(1):113-9. PubMed ID: 19233284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
